Search for Clinical Trial Results

Sponsored By

Hemorrhagic Fevers, Viral - 25 Studies Found

Status Study
Enrolling by invitation Study Name: Intravenous Ribavirin Protocol to Treat Individuals With Viral Hemorrhagic Fever
Condition: Viral Hemorrhagic Fever
Date: 2015-06-24
Interventions: Drug: Ribavirin
  • Loading do
    		•
    Enrolling by invitation Study Name: Ribavirin for Hemorrhagic Fever With Renal Syndrome
    Condition: Hemorrhagic Fever With Renal Syndrome
    Date: 2008-02-13
    Interventions: Drug: Ribavirin 7 Day multiple dosing regime based on weight and dosage day
    Active, not recruiting Study Name: Phase I Study to Evaluate Basic Pharmacodynamic, Pharmacological and Toxicological Effects of the Newly Developed Crimean-Congo Hemorrhagic Fever Vaccine for Humans
    Condition: Crimean-Congo Hemorrhagic Fever
    Date: 2017-01-11
    Interventions:
    • Biological: KIRIM-KONGO-VAX Cr
    Withdrawn Study Name: Ribavirin for Hemorrhagic Fever With Renal Syndrome in Germany
    Condition: Hemorrhagic Fever With Renal Syndrome
    Date: 2009-03-24
    Interventions: Drug: Virazole (Ribavirin) Duration of Subject Participati
    Active, not recruiting Study Name: Phase 2a Immunogenicity Study of Hantaan/Puumala Virus DNA Vaccine for Prevention of Hemorrhagic Fever
    Condition: Hemorrhagic Fever With Renal Syndrome
    Date: 2014-04-14
    Interventions:
    • Biological: HTNV/PUUV DNA vaccine

    Enrolling by invitation Study Name: Treatment of Viral Hemorrhagic Fevers With Intravenous Ribavirin in Military Treatment Facilities
    Condition:
    • Crimean-Congo Hemorrhagic Fever
    • Lassa Fever

    Date: 2009-10-08
    Interventions: Drug: Ribavirin (Virazole) Injection The drug is to be adm
    Completed Study Name: Activated Recombinant Human Factor VII in Patients With Dengue Haemorrhagic Fever
    Condition:
    • Acquired Bleeding Disorder
    • Dengue Haemorrhagic Fever

    Date: 2012-05-14
    Interventions:
    • Drug: activated recombinant human factor VII

    Active, not recruiting Study Name: Clinical Trial of Ebola Vaccines cAd3-EBO, cAd3-EBOZ and MVA-EbolaZ in Healthy Adults in Uganda
    Condition: Hemorrhagic Fever, Ebola
    Date: 2015-01-29
    Interventions:
    • Biological: cAd3-EBOZ cAd3 vac
    Recruiting Study Name: Open Study of the Duration of Immunity After Vaccination With GamEvac-Combi
    Condition: Ebola Hemorrhagic Fever
    Date: 2016-09-14
    Interventions: Procedure: blood sampling collection It is an observational study; no interventions are planned in the c
    Completed Study Name: Study to Evaluate the Safety, Tolerability, and Immunogenicity of Hantaan and Puumala Virus DNA Vaccines
    Condition: Hemorrhagic Fever With Renal Syndrome
    Date: 2011-12-23
    Interventions: Biological: Vaccine/device combination for prevention of HFRS PUUV DNA Vaccine, 2.0mg/ml TDS-IM injectio
    Next >>>